SPK-10001

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SPK-10001, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease [Phase 1, Phase 2]